Skip to main content

Glimpse Group Inc

For the period ended Mar 31, 2024. Filed May 15, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 15, 2024

BTLN$3.67+4.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended March 31,
2024 · 2023
Cash flows from operating activities:
Net loss$(2,400,066)$(9,296,960)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and depreciation1,040,7591,645,846
Common stock and stock option based compensation for employees and board of directors1,742,1262,784,667
Accrued non cash performance bonus fair value adjustment(551,236)-
Acquisition contingent consideration fair value adjustment(4,317,524)(677,113)
Impairment of goodwill and intangible assets901,204479,182
Issuance of common stock to vendors as compensation88,4725,238
Adjustment to operating lease right-of-use assets and liabilities(99,144)(15,056)
Changes in operating assets and liabilities:
Accounts receivable478,598(48,340)
Deferred costs/contract assets86,347519,673
Prepaid expenses and other current assets(251,030)(120,436)
Other assets(1,506)149,962
Accounts payable(214,705)(525,832)
Accrued liabilities(388,644)(149,673)
Deferred revenue/contract liabilities(396,546)(2,348,561)
Net cash used in operating activities(4,282,895)(7,597,403)
Cash flow from investing activities:
Purchases of equipment(19,346)(139,420)
Acquisitions, net of cash acquired-(2,522,756)
Purchase of investments-(8,197)
Net cash used in investing activities(19,346)(2,670,373)
Cash flows provided by financing activities:
Proceeds from securities purchase agreement, net2,968,501-
Proceeds from exercise of stock options-66,111
Cash provided by financing activities2,968,50166,111
Net change in cash, cash equivalents and restricted cash(1,333,740)(10,201,665)
Cash, cash equivalents and restricted cash, beginning of year5,619,08318,249,666
Cash, cash equivalents and restricted cash, end of period$4,285,343$8,048,001
Non-cash Investing and Financing activities:
Issuance of common stock for satisfaction of contingent liability$974,647$2,093,037
Issuance of common stock for non cash performance bonus$490,360$-
Lease liabilities arising from right-of-use assets$113,182$1,221,513
Note receivable for sale of subsidiary assets$1,000,000$-
Allowance against note receivable$(1,000,000)$-
Common stock issued for acquisition$-$2,845,430
Contingent acquisition consideration liability recorded at closing$-$6,139,000
Common stock issued for purchase of intangible asset - technology$-$326,436
Issuance of common stock for satisfaction of contingent liability, net of note extinguishment$-$318,571
Extinguishment of note receivable for satisfaction of contingent liability$-$250,000
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.